The oldest person ever verified, Jeanne Calment of France, died in 1997 at the age of 122. That remains the ceiling anyone has reached, but most researchers estimate the biological upper limit for humans falls somewhere between 120 and 150 years. The global average life expectancy, by contrast, sits around 71 years, meaning most people live far shorter than what the body could theoretically sustain.
The Current Record and Average
Calment was born in Arles, France, in 1875 and lived through both World Wars, the invention of flight, and the dawn of the internet. Her record has stood for nearly three decades, and only a handful of people have come within a few years of it. The number of verified supercentenarians (people who reach 110) has grown as record-keeping has improved, but crossing 115 remains extraordinarily rare.
For the species as a whole, the World Health Organization placed global life expectancy at 71.4 years as of 2021, a figure that actually retreated to 2012 levels after the COVID-19 pandemic. That number reflects averages across every country, income level, and health system. In high-income nations, life expectancy typically hovers in the low-to-mid 80s, while in parts of sub-Saharan Africa it can fall below 60.
Why the Body Has a Built-In Limit
Your cells are not designed to replicate forever. Human cells can divide roughly 40 to 60 times before they stop, enter a state of permanent shutdown, and eventually die. This cap, known as the Hayflick limit, exists because protective structures on the ends of your chromosomes shorten with each division. Once they get too short, the cell can no longer copy itself safely. This is one of the core mechanisms that makes aging inevitable at the cellular level.
Beyond individual cells, the body faces a broader pattern that biologists call the “compensation effect of mortality.” Improvements in medicine, nutrition, and sanitation have made younger people far healthier than they were a century ago. But that doesn’t push the maximum lifespan much further. Instead, it compresses the period of decline: you stay healthier longer, then deteriorate faster as you approach the species limit. Researchers at Brookings note that somewhere between age 90 and 95, the human body reaches its functional boundary regardless of how healthy the person was in earlier decades. The theoretical species lifespan estimate sits around 97 years, with outliers like Calment representing the far statistical tail.
How Much Genetics Matter
About 25 percent of the variation in human lifespan comes from genetics. That’s a meaningful share, but it means roughly three-quarters of the difference between a short life and a long one comes down to environment, behavior, and luck. Studies of identical twins raised apart have consistently pointed to this ratio. Certain gene variants do appear more frequently in centenarians, but no single “longevity gene” has been identified that reliably extends life by a significant margin. The genetic contribution seems to involve dozens or hundreds of small effects rather than one master switch.
What the Longest-Lived Communities Do Differently
Researchers studying populations with unusually high concentrations of people living past 100 have identified a set of overlapping lifestyle patterns. These communities, found in places like Okinawa (Japan), Sardinia (Italy), and the Nicoya Peninsula (Costa Rica), share nine broad habits:
- Natural movement: daily physical activity built into routines like walking, gardening, or manual work, rather than gym sessions
- Sense of purpose: a clear reason to get up each morning
- Stress management: regular routines for unwinding, whether napping, praying, or socializing
- Eating to 80 percent full: stopping before feeling stuffed
- Plant-heavy diets: beans, whole grains, and vegetables forming the core of meals, with meat eaten sparingly
- Moderate alcohol: small, regular amounts (typically wine) rather than binge drinking or total abstinence
- Strong social circles: close friend groups that reinforce healthy behaviors
- Faith or spiritual practice: regular participation in a faith community
- Family priority: keeping aging parents nearby and investing in children and partners
None of these habits are exotic. The pattern that emerges is one of consistent moderation, social connection, and physical activity woven into everyday life rather than treated as a separate health project.
Measuring How Fast You’re Actually Aging
Your chronological age (years since birth) and your biological age (how worn your body actually is) can diverge significantly. One of the most promising tools for measuring this gap is the epigenetic clock, which looks at chemical tags on your DNA called methylation markers. These tags change in predictable ways as the body ages, and researchers can use the pattern to estimate how old your cells really are.
First-generation epigenetic clocks mostly just matched biological age to chronological age. Newer versions, like one called PhenoAge, incorporate blood chemistry markers such as glucose levels to better reflect physiological wear. These second-generation clocks are more accurate at predicting age-related disease and could eventually be used to measure whether anti-aging interventions are actually working. Two people who are both 55 on the calendar might have biological ages of 48 and 62, with very different health trajectories ahead of them.
Anti-Aging Research in Humans
The most closely watched effort to treat aging itself is the TAME trial (Targeting Aging with Metformin), a planned six-year study across 14 research institutions involving over 3,000 people aged 65 to 79. Metformin is a cheap, widely used diabetes drug that has shown signs in observational data of reducing age-related diseases across the board. The trial’s deeper goal is to convince the FDA to recognize aging as a treatable condition. If that happens, it would open the door for pharmaceutical companies to develop and market drugs specifically targeting the aging process, not just individual diseases like cancer or heart failure. As of now, the trial is still in the fundraising phase.
Another active area involves drugs called senolytics, which selectively kill senescent cells. These are cells that have stopped dividing but haven’t died. They accumulate with age and pump out inflammatory signals that damage surrounding tissue. In a pilot study published in The Lancet, older adults at risk for Alzheimer’s took a senolytic combination for just two days every two weeks over 12 weeks. Those with the lowest cognitive scores at the start showed a statistically significant improvement of 2.0 points on a standard cognitive test. Reductions in a key inflammatory marker were correlated with cognitive gains. The results are preliminary, involving a small group, but they demonstrate that targeting aging cells directly can produce measurable changes in humans, not just lab mice.
One intriguing feature of senolytics is that they don’t need to be taken continuously. Because senescent cells don’t replicate and take weeks to accumulate, brief intermittent doses appear to be as effective as constant treatment in preclinical work. That “hit and run” approach could reduce side effects compared to drugs taken daily.
The Realistic Outlook
For most people alive today, the practical ceiling is somewhere in the late 80s to mid-90s with good health habits and some genetic luck. Reaching 100 is achievable but uncommon. Reaching 110 is extremely rare. And reaching 120 has happened exactly once in verified history. The compression of morbidity means that modern medicine is very good at keeping you healthy for most of your life, but the final decline, once it begins, tends to be steep and fast. Living longer and living well for longer are related but distinct goals, and the latter is where most of the real progress is happening.